Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
New heart valve study aims to improve lives of people with birth defects
Disease control OngoingThis study looks at how well the Medtronic Harmony Transcatheter Pulmonary Valve (TPV) works when used by doctors in everyday practice. It involves 150 people with congenital heart disease who need a new pulmonary valve. The main goal is to see if the valve works properly and saf…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 01, 2026 23:14 UTC
-
Heart valve showdown: which TAVR device works best for small aortas?
Disease control OngoingThis study compares two types of replacement heart valves (self-expanding vs. balloon-expandable) in over 1,100 people with severe aortic stenosis and a small aortic valve opening. The goal is to see which valve works better and has fewer complications like death, stroke, or the …
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New heart valve procedure offers hope for High-Risk patients
Disease control OngoingThis study tests a new device called the Intrepid Transcatheter Mitral Valve Replacement System for people with severe mitral regurgitation (a leaky heart valve) who are too high-risk for open-heart surgery. The procedure uses a thin tube inserted through a vein in the leg to pla…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New heart valve device tested in High-Risk chinese patients
Disease control OngoingThis study is testing a new heart valve device (Medtronic CoreValve Evolut PRO) in 52 Chinese patients with severe aortic stenosis who are too high-risk for open-heart surgery. The device is placed through a tube in an artery to replace the diseased valve without major surgery. R…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New hope for heart patients: less severe valve disease may now be treatable
Disease control OngoingThis study tests whether a less invasive heart valve replacement (TAVR) can help people with moderate aortic stenosis, a condition where the heart's aortic valve is narrowed but not yet severe. About 650 participants will receive the Evolut TAVR system to see if it reduces risks …
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC